CD2 is a surface adhesion molecule involved in T-cell activation, and while its loss has been described in various peripheral T-cell lymphomas, its absence is less frequently observed in early-stage MF. This evidence concerns the gene CD2 and peripheral T-cell lymphoma, not otherwise specified.